749216
Last Update Posted: 2010-06-02
Recruiting has ended
All Genders accepted | 50 Years + |
33 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease
The purpose of this study is to investigate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of multiple dosing Solanezumab in subjects with mild-to-moderate AD in Japanese population.
Eligibility
Relevant conditions:
Alzheimer's Disease
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov